Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of nicardipine or esmolol pretreatment on rocuronium onset for rapid sequence induction
KCT0001177Phase 3Completed
- Sponsor
- Korea Cancer Center Hospital
- Start
- Mar 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Nicardipine pretreatment + rocuronium, Esmolol pretreatment + rocuronium and Rocuronium alone (3 arms). Primary endpoint: Onset time of rocuronium-induced neuromuscular blockade. Started Mar 2014; status: completed.
02
Drugs
nicardipineesmololrocuronium
Beyond the preview
Go deeper on KCT0001177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001177.